NCT02034357View on ClinicalTrials.gov

Sleep Disordered Breathing and Its Impact on Neuro-cognitive Performance and Quality of Life in Parkinson Disease

NACompletedINTERVENTIONAL
Enrollment

89

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

August 31, 2013

Study Completion Date

March 31, 2016

Conditions
Parkinson's DiseaseSleep Disordered BreathingSleep Obstructive Apnea
Interventions
OTHER

Neurocognitive function

Each eligible participant will complete a neuro-cognitive assessment as measured by CVLT at the beginning of the study. Neurocognitive evaluations will be repeated at 4-month and 1-year follow-up.

OTHER

Sleep evaluations

Each eligible participant will complete sleep questionnaires and undergo a baseline sleep study at the beginning of the study. The sleep questionnaires will be repeated at 4-month and 1-year follow-up.

Trial Locations (1)

33136

University of Miami, Miami

All Listed Sponsors
collaborator

National Parkinson Foundation

OTHER

lead

University of Miami

OTHER

NCT02034357 - Sleep Disordered Breathing and Its Impact on Neuro-cognitive Performance and Quality of Life in Parkinson Disease | Biotech Hunter | Biotech Hunter